INSIGHTS ON CLINICAL TRIAL PARTNERING
-
How CROs, Sites, PIs, And Sponsors Work Better Together
Each role is critical, yet operating in isolation results in slower timelines, duplicated effort, and missed opportunities. When collaboration replaces coordination, trials gain speed, quality, and patient trust.
-
Driving Greater Efficiency Through Modular Trial Design
As clinical trials grow more complex and patient-centric, traditional site-based models are proving insufficient and prompting the rise of modular, technology-enabled delivery strategies.
-
Community-Focused Site Networks Transforming Clinical Trials
Leveraging a site network has proven to ease study enrollment, contracting, and budgeting, while also reducing overall study cost and timelines.
-
In-Vivo CAR Therapies — Global Research And Development Landscape
Delve into the evolving in-vivo CAR therapy landscape, examining key technological innovations, major industry players, recent clinical progress, and regulatory developments.
-
The Promise Of IQVIA One Home For Sites: A Site CEO's Perspective2/28/2025
By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.
-
10 Expert Recommendations For Smoother EDC Implementations1/30/2026
Help your small biotech navigate Electronic Data Capture (EDC) in a trial landscape that requires a shift from "big pharma" thinking toward strategies that prioritize agility and data control.
-
How To Capture Growth In The Expanding Metabolic Drug Market12/2/2025
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
Accelerate Drug Development With Master Protocols5/15/2025
Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.
-
Relieving The Strain Of Publishing During Regulatory Registration8/7/2024
Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Sikich SuiteSuccess for CROs can completely transform the CRO business with resource management and finance. Explore some ways SuiteSuccess for CROs helps you control and build CRO business growth.
-
Accelerate your biotech trials in Australia—cut costs by up to 60%, enroll patients in as little as 4–6 weeks, and generate FDA- and EMA-accepted data with no IND required.
-
Rare disease clinical studies demand a specialized full-service CRO with expertise in enrollment, site selection, and global regulatory knowledge for accelerated recruitment.
-
Navigating diagnostic development requires deep scientific expertise and adept regulatory support. Comprehensive solutions offer biospecimens, biomarker development, clinical trial support, and global regulatory services.
-
Partner with Signant Health to enhance trial performance. Our comprehensive eClinical suite and expertise, combined with your CRO’s capabilities, ensure standout proposals and successful studies.